Egypt authorizes Pfizer’s COVID-19 vaccine for 12 to 15 year-olds
Prime minister directs government to take all precautionary measures against new COVID-19 variant Omicron
Doctor injecting vaccination on child boy arm against Covid-17, Coronavirus desease. Healthy and medical concept. Image used for illustrative purpose.
By Staff Writer, Arab News
CAIRO: Egypt authorized on Sunday Pfizer’s COVID-19 vaccine for children aged 12-15, the cabinet said in a statement.
The step effectively lowers the minimum age of eligibility to receive the two-shot vaccine in Egypt, which was 15 years old previously.
Meanwhile, Prime Minister Mostafa Madbouly directed the government to take all precautionary measures against the new COVID-19 variant Omicron, noting the decision to halt all direct flights with South Africa.
His comments came during a meeting of a medical group to combat coronavirus, the state news agency (MENA) reported.
Khaled Abdel Ghaffar, higher education and acting health minister, reviewed a report on the current local and international epidemical situation and the developments of the new variant, adding that the report confirmed there are no Omicron cases detected in Egypt till now.
He said that about 45.2 million vaccine doses had been administered, with 15.6 million people having received both doses.
On Friday, Egypt suspended direct flights to and from South Africa due to concerns about a new variant of the COVID-19 virus.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW